vs
Side-by-side financial comparison of DORIAN LPG LTD. (LPG) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
DORIAN LPG LTD. is the larger business by last-quarter revenue ($120.0M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, DORIAN LPG LTD. posted the faster year-over-year revenue change (48.7% vs 27.7%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -7.9%).
Dorian LPG Ltd. is a leading international shipping company focused on the seaborne transportation of liquefied petroleum gas (LPG). It owns and operates a modern fleet of very large gas carriers, serving energy and petrochemical industry clients across key markets including North America, Asia and Europe.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
LPG vs PBYI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $120.0M | $75.5M |
| Net Profit | $47.2M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 42.8% | 22.7% |
| Net Margin | 39.3% | — |
| Revenue YoY | 48.7% | 27.7% |
| Net Profit YoY | 120.9% | — |
| EPS (diluted) | $1.11 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $120.0M | $75.5M | ||
| Q3 25 | $124.1M | $54.5M | ||
| Q2 25 | $84.2M | $52.4M | ||
| Q1 25 | $75.9M | $46.0M | ||
| Q4 24 | $80.7M | $59.1M | ||
| Q3 24 | $82.4M | $80.5M | ||
| Q2 24 | $114.4M | $47.1M | ||
| Q1 24 | $141.4M | $43.8M |
| Q4 25 | $47.2M | — | ||
| Q3 25 | $55.4M | $8.8M | ||
| Q2 25 | $10.1M | $5.9M | ||
| Q1 25 | $8.1M | $3.0M | ||
| Q4 24 | $21.4M | — | ||
| Q3 24 | $9.4M | $20.3M | ||
| Q2 24 | $51.3M | $-4.5M | ||
| Q1 24 | $79.2M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 42.8% | 22.7% | ||
| Q3 25 | 47.8% | 17.6% | ||
| Q2 25 | 18.5% | 12.7% | ||
| Q1 25 | 19.4% | 8.7% | ||
| Q4 24 | 29.0% | 22.6% | ||
| Q3 24 | 23.2% | 27.4% | ||
| Q2 24 | 48.5% | -4.6% | ||
| Q1 24 | 58.3% | -5.3% |
| Q4 25 | 39.3% | — | ||
| Q3 25 | 44.6% | 16.2% | ||
| Q2 25 | 12.0% | 11.2% | ||
| Q1 25 | 10.7% | 6.5% | ||
| Q4 24 | 26.5% | — | ||
| Q3 24 | 11.4% | 25.2% | ||
| Q2 24 | 44.9% | -9.6% | ||
| Q1 24 | 56.0% | -11.0% |
| Q4 25 | $1.11 | $0.26 | ||
| Q3 25 | $1.30 | $0.17 | ||
| Q2 25 | $0.24 | $0.12 | ||
| Q1 25 | $0.17 | $0.06 | ||
| Q4 24 | $0.50 | $0.40 | ||
| Q3 24 | $0.22 | $0.41 | ||
| Q2 24 | $1.25 | $-0.09 | ||
| Q1 24 | $1.96 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $294.5M | $97.5M |
| Total DebtLower is stronger | $513.2M | $22.7M |
| Stockholders' EquityBook value | $1.1B | $130.3M |
| Total Assets | $1.8B | $216.3M |
| Debt / EquityLower = less leverage | 0.47× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $294.5M | $97.5M | ||
| Q3 25 | $268.3M | $94.4M | ||
| Q2 25 | $277.9M | $96.0M | ||
| Q1 25 | $316.9M | $93.2M | ||
| Q4 24 | $314.5M | $101.0M | ||
| Q3 24 | $348.6M | $96.7M | ||
| Q2 24 | $353.3M | $96.8M | ||
| Q1 24 | $282.5M | $107.2M |
| Q4 25 | $513.2M | $22.7M | ||
| Q3 25 | $526.4M | $34.0M | ||
| Q2 25 | $539.6M | $45.3M | ||
| Q1 25 | $553.3M | $56.7M | ||
| Q4 24 | $565.9M | $68.0M | ||
| Q3 24 | $579.0M | $79.3M | ||
| Q2 24 | $592.1M | $90.7M | ||
| Q1 24 | $605.1M | $102.0M |
| Q4 25 | $1.1B | $130.3M | ||
| Q3 25 | $1.1B | $115.3M | ||
| Q2 25 | $1.0B | $104.7M | ||
| Q1 25 | $1.0B | $97.1M | ||
| Q4 24 | $1.1B | $92.1M | ||
| Q3 24 | $1.1B | $71.1M | ||
| Q2 24 | $1.1B | $48.5M | ||
| Q1 24 | $1.0B | $51.0M |
| Q4 25 | $1.8B | $216.3M | ||
| Q3 25 | $1.8B | $202.9M | ||
| Q2 25 | $1.7B | $194.9M | ||
| Q1 25 | $1.8B | $196.2M | ||
| Q4 24 | $1.8B | $213.3M | ||
| Q3 24 | $1.9B | $220.7M | ||
| Q2 24 | $1.9B | $205.0M | ||
| Q1 24 | $1.8B | $214.1M |
| Q4 25 | 0.47× | 0.17× | ||
| Q3 25 | 0.49× | 0.30× | ||
| Q2 25 | 0.52× | 0.43× | ||
| Q1 25 | 0.53× | 0.58× | ||
| Q4 24 | 0.53× | 0.74× | ||
| Q3 24 | 0.53× | 1.12× | ||
| Q2 24 | 0.53× | 1.87× | ||
| Q1 24 | 0.59× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.8M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 1.71× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.8M | $14.4M | ||
| Q3 25 | $46.4M | $9.7M | ||
| Q2 25 | $814.5K | $14.1M | ||
| Q1 25 | $50.2M | $3.6M | ||
| Q4 24 | $24.3M | $15.6M | ||
| Q3 24 | $57.3M | $11.0M | ||
| Q2 24 | $41.2M | $1.0M | ||
| Q1 24 | $154.2M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 1.71× | — | ||
| Q3 25 | 0.84× | 1.10× | ||
| Q2 25 | 0.08× | 2.41× | ||
| Q1 25 | 6.20× | 1.21× | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 6.08× | 0.54× | ||
| Q2 24 | 0.80× | — | ||
| Q1 24 | 1.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
